# Sun Pharma

Type: Company (SUNPHARMA.NS)

Source: GetYourBrief — https://getyourbrief.com/entity/sun-pharma
Canonical HTML page: https://getyourbrief.com/entity/sun-pharma

## Recent coverage (3 stories, network-wide)

### India-UK FTA Drives $981M Pharma Export Target, 8.66% Jump by FY27
2026-07-27 10:10:49 · Sector: bio · Sentiment: Positive · Impact: 6/10 · Sources: 2

The zero-tariff India-UK trade pact propels Indian pharmaceutical exports to a projected $981M, offering biotech and pharma firms expanded market access, lower costs, and new collaboration channels in R&D and manufacturing.
Full story: https://getbiobrief.com/story/india-uk-fta-pharma-exports-981-million-fy27

### Sensex Gains 266 Points as IT Rally Offsets Oil Surge; Nifty Above 24,100
2026-07-16 09:46:05 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Indian equities opened higher despite a 12% weekly oil spike and Middle East turmoil. The Sensex added 266 points and Nifty held above 24,100, powered by IT and consumer durables. While PSU banks and realty slipped, gold steadied on dovish Fed bets.
Full story: https://getfinancebrief.com/story/sensex-nifty-open-higher-it-consumer-durables-oil-surge

### Sensex Surges 700+ Points, Nifty Above 24,000: IT Index Jumps 2.08%
2026-07-10 09:49:05 · Sector: finance · Sentiment: Neutral · Impact: 6/10 · Sources: 10

Indian equity markets surged on July 10, 2026, with Sensex gaining over 700 points to trade at 77,441.52 and Nifty reclaiming the 24,000 level. The Nifty IT index led the rally with a 2.08% jump, buoyed by strong earnings expectations and positive global cues, while gold and crude reflected a nuanced risk environment.
Full story: https://getfinancebrief.com/story/sensex-nifty-surge-july-10-2026-it-leads

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.